Related Articles
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs
<em>Lespedeza homoloba</em> enhances the immunosuppressive milieu of adipose tissue and suppresses fasting blood glucose
Myeloid‑derived suppressor cell accumulation induces Treg expansion and modulates lung malignancy progression
Increased frequency of regulatory T cells in the peripheral blood of patients with endometrioid adenocarcinoma